Candel Therapeutics, Inc. Business Finance Contracts & Agreements

12 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Description of Registered Securities and Registration Rights Agreement – Candel Therapeutics, Inc.
Registration Rights Agreements
Candel Therapeutics, Inc.
Biotechnology
2025
Candel Therapeutics, Inc. Form of Pre-Funded Warrant to Purchase Common Stock
Warrant Agreements
Candel Therapeutics, Inc.
Biotechnology
NY
2024
Underwriting Agreement for Sale of Common Stock and Pre-Funded Warrants by Candel Therapeutics, Inc. to Underwriters Led by Citigroup, BofA Securities, and Canaccord Genuity
Underwriting Agreements
Candel Therapeutics, Inc.
Biotechnology
NY
2024
First Amendment to Loan and Security Agreement between Silicon Valley Bank and Candel Therapeutics, Inc.
Modification Agreements
Candel Therapeutics, Inc.
Biotechnology
MA
2023
Loan and Security Agreement between Silicon Valley Bank and Borrower (Schedule I)
Loan Agreements
Candel Therapeutics, Inc.
Biotechnology
MA
2022
Description of Candel Therapeutics, Inc. Securities Registered Under Section 12 of the Exchange Act
Registration Rights Agreements
Candel Therapeutics, Inc.
Biotechnology
2022
Advantagene, Inc. Warrant to Purchase Common Stock Agreement with PBM ADV Holdings, LLC (2018)
Warrant Agreements
Candel Therapeutics, Inc.
Biotechnology
DE
2021
Advantagene, Inc. Warrant to Purchase Common Stock Agreement with PBM ADV Holdings, LLC (2018)
Warrant Agreements
Candel Therapeutics, Inc.
Biotechnology
DE
2021
Stock Certificate Assignment and Transfer Form for Unregistered Securities
Stock Agreements
Candel Therapeutics, Inc.
Biotechnology
2021
Underwriting Agreement between Candel Therapeutics, Inc. and Jefferies LLC, Credit Suisse Securities (USA) LLC, BMO Capital Markets Corp., and UBS Securities LLC
Underwriting Agreements
Candel Therapeutics, Inc.
Biotechnology
MA
2021
Advantagene, Inc. Warrant to Purchase Series A Convertible Preferred Stock (April 5, 2016)
Warrant Agreements
Candel Therapeutics, Inc.
Biotechnology
DE
2021
Amended and Restated Investors' Rights Agreement among Advantagene, Inc. and Investors (March 19, 2019)
Investor Rights Agreements
Candel Therapeutics, Inc.
Biotechnology
DE
2021